News & Events

Pharmaceutical Breakthrough

Pharmaceutical and biotech companies have made huge advances recently in the fight against cancer. The Daily Mail has published a heart-warming article highlighting the huge effect that a new class of drugs called Antibody Drug Conjugates (ADCs) drugs can have on people. http://www.dailymail.co.uk/health/article-2567455/Cancer-patients-lethal-70-tumours-disappear-just-two-WEEKS-thanks-pioneering-treatment.html

A British man suffering from a rare form of lymphoma was given only weeks to live after scans showed that his body was riddled with more than 70 individual tumours. However he managed to turn this around after trying out new US drug Brentuximab Vedotin. Ian Brooks, 47, was the first person outside the US to be offered Brentuximab Vedotin  ADC as part of a clinical trial. After only 12 weeks all tumours had been eradicated and he is now in remission. .

This article illustrates the significance and advancements of drugs currently being developed within the pharmaceutical industry. This article also provides an insight into the amazing effects that clinical trials can have in improving and even saving lives.

Get In Touch.


By ticking the box and clicking “Submit” below, you consent to receiving thought leadership, industry news, and invitations by email or other electronic means, which Symbiosis Pharmaceutical Services believes may be of value to you, relevant to your work and tailored to your professional profile and interests. This may include promotional information on products, services and events provided or organised by Symbiosis Pharmaceutical Services. By clicking the "Submit” button, you confirm that the information you have provided above is correct, and you agree to Symbiosis' processing of your personal data, including its transfer internationally and to third parties, in accordance with it's privacy policy.